HPV vaccines and cancer prevention, science versus fiction
(Please note: this lecture may possibly be presented by Christopher A. Shaw, B.Sc., M.Sc., PhD)
The rationale behind current worldwide HPV vaccination programs starts from two basic premises: 1) that HPV vaccines will prevent cervical cancers and save lives, and 2) have no risk of serious side effects. Therefore, efforts should be made to get as many pre-adolescent girls vaccinated. Careful analysis of HPV vaccine pre- and post-licensure data shows, however, that both of these premises are at odds with factual evidence and are largely derived from gross misinterpretation of available data.
Lucija Tomljenovic, PhD
Lucija Tomljenovic holds a PhD in biochemistry and is currently a senior research fellow at the University of British Columbia School of Medicine in Vancouver, BC, Canada. Her research focuses on neuro- and immuno-toxicity of vaccines. In particular, Tomljenovic investigates mechanisms by which vaccines and their ingredients may induce neurological and autoimmune diseases.
